Incyte Corporation

Michael B Thornton

Henry Yue

Mariah R Baughn

April J A Hafalia

Ameena R Gandhi

Monique G Yao

Yan Lu

Craig H Ison

Danniel B Nguyen

Vicki S Elliott

Rajagopal Gururajan

Anita Swarnakar

Ian J Forsythe

Ernestine A Lee

Wen Luo

Thomas W Richardson

Joseph P Marquis

Shanya D Becha

Soo Yeun Lee

Uyen K Tran

Reena Khare

Pei Jin

Narinder K Chawla-Walia

Joana X Li

Amy D Wilson

Olga Bandman

Chandra S Arvizu

Neil Burford

Li Ding

Narinder K Chawla

Catherine M Tribouley

Jayalaxmi Ramkumar

Preeti G Lal

Janice K Au-Young

Y Tom Tang

Dyung Aina M Lu

Yalda Azimzai

Bridget A Warren

Yuming Xu

Kavitha Thangavelu

Gregory Marcus

Farrah A Khan

Jennifer L Policky

Liam Kearney

John D Burrill

Kurt A Zingler

Preeti G Lai

Jennifer A Griffin

Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Antibodies to human &#x3b2;-adrenergic receptor kinase

Human &#x3b2;-adrenergic receptor kinase polypeptide and methods

Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Human &#x3b2;-adrenergic receptor kinase nucleic acid molecule

The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.

Human cAMP-dependent protein kinase beta-catalytic subunit

The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.

Human protein phosphatase 2C

Growing community of inventors

Oakland, CA, United States of America

Michael B Thornton